[
  {
    "ts": null,
    "headline": "Merck (MRK): Valuation Perspective as Groundbreaking Cancer Trial Wins Drive New Investor Focus",
    "summary": "Merck (MRK) made headlines at the ESMO Congress by releasing new data from a suite of major Phase 3 clinical trials, each highlighting practice-changing advances for some hard-to-treat cancers. Results from Keytruda-based regimens included the first immune checkpoint inhibitor to show survival benefits in platinum-resistant recurrent ovarian cancer, improved outcomes in muscle-invasive bladder cancer, and extended event-free and overall survival for non-small cell lung cancer. See our latest...",
    "url": "https://finnhub.io/api/news?id=d99fa11948d811309c52d16a039eb2ad6c425a8169d6c338726679bf2a16ba4b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761135143,
      "headline": "Merck (MRK): Valuation Perspective as Groundbreaking Cancer Trial Wins Drive New Investor Focus",
      "id": 137187976,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) made headlines at the ESMO Congress by releasing new data from a suite of major Phase 3 clinical trials, each highlighting practice-changing advances for some hard-to-treat cancers. Results from Keytruda-based regimens included the first immune checkpoint inhibitor to show survival benefits in platinum-resistant recurrent ovarian cancer, improved outcomes in muscle-invasive bladder cancer, and extended event-free and overall survival for non-small cell lung cancer. See our latest...",
      "url": "https://finnhub.io/api/news?id=d99fa11948d811309c52d16a039eb2ad6c425a8169d6c338726679bf2a16ba4b"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Calls Danaher “Once Incredibly Well-Run Company”",
    "summary": "Danaher Corporation (NYSE:DHR) is one of the stocks in Jim Cramer’s recent game plan. Cramer showed slight optimism around the company’s upcoming earnings, as he remarked: “… and Charitable Trust club name Danaher, one of our biggest laggards, may report the first of many good quarters after a shocking multiple-year dry spell for this once […]",
    "url": "https://finnhub.io/api/news?id=f0ff704f126565cb28b567aaeee91efa3b3d7ed8e6057a03d1a833579262c217",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761132566,
      "headline": "Jim Cramer Calls Danaher “Once Incredibly Well-Run Company”",
      "id": 137187977,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Danaher Corporation (NYSE:DHR) is one of the stocks in Jim Cramer’s recent game plan. Cramer showed slight optimism around the company’s upcoming earnings, as he remarked: “… and Charitable Trust club name Danaher, one of our biggest laggards, may report the first of many good quarters after a shocking multiple-year dry spell for this once […]",
      "url": "https://finnhub.io/api/news?id=f0ff704f126565cb28b567aaeee91efa3b3d7ed8e6057a03d1a833579262c217"
    }
  }
]